The Weekly Roundup: October 7-11

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

BREAKING NEWS: Additional Study Confirms Reports of Benzene Presence, Formation in Benzoyl Peroxide Products at Room Temperature

New peer-reviewed research published in the Journal of Investigative Dermatology examined 111 products at room temperature.

Join Your Dermatology NP/PA Community at the Elevate Derm PA NP Conference

Connect with peers, mentors, and potential collaborators at the fully accredited Elevate Derm PA NP Conference, from November 7-10, 2024.

FDA Approves sNDA for Actinic Keratosis Drug Dosage Expansion

The expanded dosage aims to provide healthcare providers with greater flexibility in treating larger or multiple areas affected by AK.

Working to Improve Mental Health

Join Dermatology Times in honoring World Mental Health Day on Oct 10, 2024.

Tralokinumab Shows Long-Term Efficacy for AD in Sensitive Areas

A poster presented at the EADV Congress revealed the drug's long-term efficacy in treating AD, particularly in the head and neck regions.

Embrace the Fun in Fundamentals

Dermatology offers the power of choice, and it can be exactly what you make of it, writes our Fall Editor in Chief Raj Chovatiya, MD, PhD.

Valisure's David Light Shares Insights Into Newly-Published Benzene and BPO Data

Light delves into the science behind the new peer-reviewed data assessing benzene presence and formation in benzoyl peroxide products.

Journal Digest: October 8

This week’s collection of the latest dermatologic studies includes the potential association between hidradenitis suppurativa and infertility, refractory pediatric atopic dermatitis treated with dupilumab and abrocitinib, and omalizumab's efficacy in chronic inducible urticaria.

Addressing Challenging Cases of Acne: Part 1

In a Dermatology Times Case-Based Roundtable event, Hilary Baldwin, MD, shared pearls for challenging acne cases.

Phase 2b Trial Reinforces Zasocitinib’s Safety Profile

Melinda Gooderham, MSc, MD, FRCPC, emphasized the significance of the study’s results, showcasing stable laboratory parameters over a 12-week trial.

Experts Delve Into Upadacitinib vs Dupilumab: Insights From LEVEL UP

Christopher Bunick, MD, PhD, and Raj Chovatiya, MD, PhD, discuss results of an open-label phase 3b/4 study for atopic dermatitis.

Q&A: Amy McMichael, MD, Discusses 48-Week VISIBLE Study Results on Psoriasis in Patients With Skin of Color

Over 70% of patients achieved clear or minimal skin by week 48, with a 90% retention rate in diverse patients with PsO.

Clinical Pearls for Vitiligo and Pigmentation Complexities: Part 1

In a Dermatology Times Case-Based Roundtable event, Andrew Alexis, MD, MPH, FAAD, reviewed 3 cases of patients with vitiligo treated with ruxolitinib cream.

Psychosocial Impact of Alopecia Areata on Pediatric and Adolescent Patients

A recent review found hair loss can severely impact self-esteem and body image, leading to social anxiety and emotional distress among affected youth.

Infertility Not Linked to Hidradenitis Suppurativa

In this study, the highest infertility rate was seen in the patients living with hidradenitis suppurativa; however, no direct causality was seen for this, with the authors noting diseases and symptoms comprised the only factors with a statistically significant relationship to infertility.

Highly Prevalent, Scarcely Supported: Common Skin Issues Remain Underserved

Experts shared pearls for acne and rosacea care at Maui Derm NP+PA Fall.

Evan Rieder, MD: Immersion in the Eczema Patient Experience

AbbVie's Eczema Experience Pop-Up event recently provided attendees with immersive insights into the physical and psychosocial toll associated with eczema.

Bimekizumab Demonstrates Safety and Efficacy in Elderly Patients with Psoriasis

The IL-17 inhibitor demonstrated biologic-level efficacy in moderate to severe plaque psoriasis.

Benzene in Benzoyl Peroxide at Room Temperature: What Comes Next?

Christopher Bunick, MD, PhD, reviews the latest findings on benzene in benzoyl peroxide, highlighting the importance of proper storage and patient safety.

Philip Mease, MD, Discusses Head-to-Head BE BOLD Clinical Trial

Mease, the lead investigator on the trial, spoke about comparing varying mechanisms of action, primary and secondary endpoints, and how the results of BE BOLD could affect treatment choices.

Disparities in Hidradenitis Suppurativa: A Closer Look at Skin of Color Populations

A recent review found clinical trials for HS lack diversity, limiting understanding of treatment efficacy for SOC populations.

Safe and Effective: Upadacitinib Shows Promise in PN Treatment

Significant reductions in itch scores and improved assessments of PN severity and quality of life were observed throughout the study.

Tirbanibulin Demonstrates Efficacy for Actinic Keratosis in Larger Field Treatment

The novel drug demonstrated tolerability for AK treatment when applied to a field of 100 cm2 of the face or scalp.